Welcome to The Native Antigen Company

Critical Reagents for Human Health

Antigens and Antibodies

We specialise in the development and manufacture of antigens and antibodies for viral and bacterial pathogens. We produce both native and recombinant antigens using our a range of cell expression systems and have decades of experience in bulk and scale production.

Contract Production and Assay Services

We can undertake custom projects to manufacture antigens and other proteins, prepare antibodies and develop immunoassays to support your R&D. Our development laboratories are staffed by a team of PhD molecular biologists and development scientists who are able to execute projects as short as a few days, through to long-term programmes of a year or more.

Seasonal Influenza

See our full Influenza virus product range including all the WHO recommended vaccine strains antigens for 2025 Southern and Northern Hemisphere as well as H5N1 Bird flu strains.

VISIT NOW

Matched Pair Antibodies

Enhance your antigen assay development with The Native Antigen Company’s newest market-leading tool!

.

USE TOOL

New range of HIV-1 and HIV-2 Antigens

We are pleased to announce comprehensive range of trimeric, native-like HIV-1 gp140 antigens! Learn more by clicking the button below.

LEARN MORE

Powered by Bioz

About The Native Antigen Company

The Native Antigen Company develops and manufactures premium quality antigens and antibodies as well as offering a range of services to the diagnostic and biopharmaceutical industries.

Our proprietary VirtuE™ expression system has been developed for the purpose of producing native-like proteins, which are widely adopted by leading in vitro diagnostic, vaccine and academic groups in cutting-edge R&D, where correct folding and glycosylation are vital. Our contract services range from antibody generation, to scale production of recombinant and native antigens, and bespoke assay development and QC.

Building on our recognised expertise in infectious diseases, we are expanding our portfolio to include a range of disease-state markers and other critical reagents for human health.

Hendra and Nipah Viruses: Catalysing Urgency in Vaccine Development and Diagnostic Advancements

by Olga Siemiatkowska | 9th July 2024 | Hendra Virus, Nipah Virus | 0 Comments

Hendra and Nipah viruses are two closely related pathogens that belong to the genus Henipavirus within the family Paramyxoviridae. These viruses have garnered significant attention due to their zoonotic nature and their potential to cause severe and often fatal...

Bacterial Antigens, Antibodies, and custom solutions for your research needs

by Bobby Mitchell | 1st February 2023 | Vaccines | 0 Comments

Group A Streptococcus infections on the rise The unusually high incidence of Invasive Group A Streptococcus disease (GAS), especially dangerous for children and immunocompromised adults, dominated media stories this winter. According to the UK governmental data...

Monkeypox; 3 months on

by Bobby Mitchell | 10th August 2022 | New products | 0 Comments

It has been 3 months since a new, unusually widespread outbreak of Monkeypox was first identified. What was normally a virus confined to limited infections in the West African continent is becoming a global health concern. What have we learned about this virus...

COVID-19 Underlines the Need for Universal Vaccines

by James Shore | 25th January 2022 | Disease insight, Research, Vaccines | 0 Comments

This article was originally published on Clinical Lab Manager. In recent history, humanity has witnessed numerous emerging viral diseases, including the SARS, MERS, and SARS-2 coronaviruses, as well as HIV, Zika, Ebola, and H1N1 and H3N2 influenza. None have tested...

Tick-Borne Diseases: The Need for Integrated Approaches to Human-Animal Diagnosis

by James Shore | 10th November 2021 | Borrelia, Disease insight, Disease trends, Flaviviruses, Research, Tick-Borne Disease, Vaccines | 0 Comments

This article has been published in Volume 8, Issue 3 of International Animal Health Journal. Ticks are responsible for a diverse group of neglected, and rapidly expanding diseases, affecting humans, companion animals and livestock. A growing understanding of tick-host...